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Hyperglycemia is detrimental to b-cell viability, playing a major role in the progression of b-cell loss in diabetes mellitus. The
permeability transition pore (PTP) is a mitochondrial channel involved in cell death. Recent evidence suggests that PTP
inhibitors prevent hyperglycemia-induced cell death in human endothelial cells. In this work, we have examined the involvement
of PTP opening in INS-1 cell death induced by high levels of glucose or fructose. PTP regulation was studied by measuring the
calciumretention capacityinpermeabilized INS-1 cellsandbyconfocalmicroscopy inintactINS-1cells. Celldeathwasanalyzed
by ﬂow cytometry. We ﬁrst reported that metformin and cyclosporin A (CsA) prevented Ca
2þ-induced PTP opening in
permeabilized and intact INS-1 cells. We then showed that incubation of INS-1 cells in the presence of 30mM glucose or 2.5mM
fructose induced PTP opening and led to cell death. As both metformin and CsA prevented glucose- and fructose- induced PTP
opening, and hampered glucose- and fructose- induced cell death, we conclude that PTP opening is involved in high glucose-
and high fructose- induced INS-1 cell death. We therefore suggest that preventing PTP opening might be a new approach to
preserve b-cell viability.
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Under physiological condition, glucose serum concentration
ﬂuctuates between 3.6 and 7mM,
1 whereas fructose serum
concentration remains below the limit of detection by
enzymatic methods.
2 Under diabetic conditions, fructose
serum concentration increases, most probably because
glucose is converted into fructose via the polyol pathway.
3,4
Moreover, the splanchnic territory is physiologically
exposed to high concentrations of glucose and fructose
during the postprandial period.
5 Therefore, b-cells can face
hyperglycemia or hyperfructosemia in type 2 diabetes or
when pancreatic islets are transplanted into the splanchnic
territory.
The permeability transition pore (PTP) is a Ca
2þ-sensitive
mitochondrial inner membrane channel.
6,7 Normally closed in
order to allow ATP synthesis, the PTP leads to mitochondrial
depolarization and cell death after extended opening.
8 Ca
2þ
is the single most important factor for PTP opening. The
amount of Ca
2þ required to open the pore varies according to
a number of factors. ‘PTP-inhibitors’ and so-called ‘PTP-
inducers’ refer to factors that increase and decrease the
amount of Ca
2þ required to induce PTP opening.
9 Cyclos-
porin A (CsA) is the reference PTP inhibitor, whereas
oxidative stress is well recognized as favoring PTP opening.
6
In several cell types, direct or indirect inhibition of respiratory
chain complex 1 inhibits PTP opening.
10–12 In such cells, the
antidiabetic drug metformin inhibits PTP opening via a mild
inhibition of complex 1.
11
Chronic exposure to elevated glucose or fructose concen-
trations impairs b-cells survival
13,14 by a mechanism that may
involve oxidative stress.
13,15,16 Hyperglycemia-induced oxi-
dative stress has been shown to induce mitochondrial
permeability transition and subsequent cell death in human
endothelial cells.
11 Concerning pancreatic-derived cells, CsA
has been shown to inhibit Ca
2þ-induced PTP opening in
permeabilized INS-1 and MIN-6 cells.
17 It has been proposed
that cytokine-induced apoptosis may be due to PTP opening
in pancreatic RINm5F cells
18 whereasCsA has been reported
to prevent PK11195-induced cell death in isolated human
pancreatic islets.
19 Finally, it has recently been shown that
CsA protects MIN-6 cells against Pdx1 insufﬁciency-induced
cell death, although genetic ablation of the endogenous
PTP-inducers cyclophilin D prevents diabetes in Pdx1
þ/ 
mice.
20 Whether metformin regulates PTP opening in
b-cells and whether hyperglycemia or hyperfructosemia
induces PTP opening in pancreatic-derived cells has not
been studied yet.
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CsA and metformin inhibit PTP opening in permeabilized
INS-1 cells. The Ca
2þ retention capacity (CRC) represents
the minimum Ca
2þ load required to induce PTP opening in
an entire population of mitochondria. Therefore, CRC
measurement represents a suitable method to quantify and
compare the potency of different PTP regulators. CRC is
measured by loading mitochondria with a train of Ca
2þ
pulses until a rapid Ca
2þ release occurs as illustrated in
Figure 1a.
As shown in Figure 1b, CsA increased CRC (i.e. inhibited
PTP opening) in permeabilized INS-1 cells. Interestingly,
complex 1 inhibitor rotenone also inhibited PTP opening in
that cell line. Accordingly, metformin also inhibited PTP
opening but to a lower extent, which was expected because
metformin is less potent than rotenone in complex 1
inhibition.
21
CsA and metformin prevent PTP opening in intact INS-1
cells. We next checked that CsA and metformin inhibited
PTP opening in intact INS-1 cells. PTP status was assessed
by double channel imaging of NAD(P)H autoﬂuorescence
and mitochondrial electrical membrane potential (i.e.
tetramethylrhodamine methyl ester (TMRM) ﬂuorescence)
as recently described,
22 whereas Ca
2þ-induced PTP
opening was triggered off by exposing INS-1 cells to the
Ca
2þ ionophore A23187. As shown in Figure 2 (left panels),
A23187-induced PTP opening was followed by an increase in
NAD(P)H autoﬂuorescence both in terms of intensity and
surface distribution. On the contrary, TMRM ﬂuorescence
decreased in term of intensity but not in term of surface
distribution, resulting in an increase in NAD(P)H/TMRM
surface distribution ratio. No change in the NAD(P)H and
TMRM ﬂuorescence was observed in the absence of A23187
(data not shown). As shown in Figure 2 (middle and right
panels), A23187 did not affect NAD(P)H and TMRM signals
when PTP opening was prevented by either CsA or
metformin. These data indicate that PTP opening increases
the NAD(P)H/TMRM surface distribution ratio in INS-1 cells,
as previously shown in human endothelial cells.
22
High glucose and high fructose open PTP in INS-1
cells. We next measured the NAD(P)H and TMRM
ﬂuorescence of INS-1 cells incubated in control conditions
or in the presence of 30mM glucose or 2.5mM fructose for
24h. Note that comparisons were performed only between
images acquired the same day with exactly the same
microscope settings and the same load of TMRM. As
shown in Figure 3, the NAD(P)H/TMRM surface distribution
ratio was dramatically increased when cells were incubated
in the presence of 30mM glucose or 2.5mM fructose, as
compared with the control conditions. As expected, when
PTP opening was prevented by either CsA or metformin, the
NAD(P)H/TMRM surface distribution ratio did not increase
(Figure 3). These data indicate PTP was opened in INS-1
cells exposed to 30mM glucose or 2.5mM fructose for 24h.
High glucose- and high fructose-induced PTP opening
leads to cell death. We ﬁnally studied the effect of 30mM
glucose or 2.5mM fructose on the viability of INS-1 cells. As
shown in Figure 4, B80% of the cells were alive (i.e. Annexin
V-/PI-) in control conditions. The viability of INS-1 cells was
not affected by osmotic change (exposure to mannitol),
whereas it was dramatically affected by 30mM glucose or
2.5mM fructose. Importantly, 30mM glucose-induced toxicity
was hampered by CsA or metformin, whereas 2.5mM
fructose-induced toxicity was totally prevented by CsA or
metformin, indicating that PTP opening was involved in high
glucose- and high fructose-induced cell death.
Discussion
In this work, we have reported that in INS-1 insulinoma cells
(i) both CsA and metformin inhibited PTP opening, (ii) high
glucose and high fructose led to PTP opening, (iii) PTP
inhibitors hampered high glucose- and high fructose-induced
cell death. Note that we have used a concentration of glucose
that can be observed in clinical practice, while 30mM glucose
or 2.5mM fructose are physiologically reached in the
splanchnic territory during the postprandial period.
5
Glucotoxicity (i.e. high glucose induced cell death) on b-cell
lines or islets is now well documented.
13,14 A very high
concentration of fructose (i.e. 450mM) has been shown to
induce cell death in hamster pancreatic b-cell-derived cell line
HIT.
13 Hyperglycemia or hyperfructosemia have been shown
to increase ROS production.
13,15,16 As pancreatic b-cells
express a low level of antioxidants,
23,24 this increased ROS
production probably results in an oxidative stress that may
affect the survival of b-cells. Supporting this scenario, several
antioxidants have been proved to prevent hyperglycemia-
induced cell death.
16 It is well acknowledged that oxidative
stress triggers PTP opening.
6 Whether or not high glucose
and high fructose led to PTP opening in INS-1 insulinoma cell
because they increased ROS production is not demonstrated
in this work, but this hypothesis is in agreement with the
literature.
Figure1 EffectofCsA,rotenoneandmetforminontheCa
2þ retentioncapacity
of digitonin-permeabilized INS-1 cells. (a) The incubation medium contained
250mM sucrose, 1mM Pi, 10mM Tris-MOPS, 5mM succinate, 0.25mM Calcium
Green-5N and 50mg/ml digitonin. The ﬁnal volume was 1ml (pH 7.35) at 251C.
Experiments were started by the addition of 3 10
6 INS-1 cells. Where indicated,
12.5mMC a
2þ pulses were added (arrows). (b) Represents cumulative data of
three different experiments performed as described in a, in control cells, in the
presence of 1mM CsA or 1.25mM rotenone or in cells incubated overnight in the
presence of 100mM metformin. Results are mean±S.E.; *Po0.05 versus control,
unpaired Student’s t-test
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Cell Death and DiseaseAlternatively, it has been shown that high glucose concen-
trations modulate the balance of proapoptotic and antiapop-
totic Bcl proteins in cultured human pancreatic islets by
overexpressing Bad and Bid.
25 Note, however, that among
different effects, Bcl proteins are able to regulate PTP
opening.
26–28 Therefore, the observed overexpression of
Bad and Bid, which may favor PTP opening,
27,28 remains
consistent with our results. High glucose concentration has
also been shown to activate the hexosamine pathway,
resulting in an impaired activation of PI 3-kinase/Akt survival
pathway.
29 As the activation of the survival PI 3-kinase/Akt
pathway has been shown to prevent PTP opening,
30
the activation of the hexosamine pathway may indirectly
favor PTP opening. Therefore, high glucose concentration
may (i) induce oxidative stress, (ii) modulate the Bcl proteins,
and (iii) prevent the activation of the PI 3-kinase/Akt pathway.
These phenomena are known to favor PTP opening and
might act synergistically.
In vitro studies have suggested that sulfonylurea may
induce apoptosis of pancreatic b-cell via a Ca
2þ-dependent
process.
31 Assuming that (i) sulfonylurea-induced apoptosis
involves PTP opening and (ii) secondary failure to sulfony-
lurea is due to b-cell death, one may hypothesize that
metformin would prevent or delay the risk of secondary failure
to sulfonylurea. To the best of our knowledge, such a study
has not been performed yet. However, it has been shown that
the cumulative incidence of monotherapy failure is higher with
sulfonylurea than with metformin.
32 In a prospective human
observational study measuring the risk of secondary failure to
sulfonylurea, the same percentage of patients receiving
sulfonylurea plus metformin was found in the group well
controlled with oral treatment and in the group with secondary
failure.
33 Note however that metformin seems to have been
added either after glucose rose over 300mg/dl or after
patients developed hyperglycemic symptoms,
33 that is, after
pancreatic b-cells apoptosis occurred.
Figure 2 Double channel imaging of NAD(P)H autoﬂuorescence and mitochondrial electrical membrane potential. INS-1 cells incubated in the absence (control)o r
presence of 1mM CsA or incubated overnight in the presence of 100mM metformin were loaded with 20nM TMRM and exposed to 150nM A23187. The ﬂuorescence
ofNAD(P)H(blue)andTMRM(red)wasimagedsimultaneouslyevery5min.TMRMandNAD(P)HquantiﬁcationwascalculatedwithVolocitysoftwareusingathresholdvalue
of 3 and 50, which corresponded to the highest ﬂuorescence outside cells for TMRM and NAD(P)H, respectively. ‘Area’ represents the sum of all the pixels above the
threshold. For easier comparisons, areas were normalized (divided by the corresponding area before A23187 addition) before NAD(P)H/TMRM ratios were calculated.
Histograms represent the results of three different experiments. Results are mean±S.E.; *Po0.05 versus 0min, paired Student’s t-test. Scale bar, 47mm
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Cell Death and DiseaseBy reducing the mitochondria-related toxicity of high
glucose and high fructose level in b-cells, pharmacological
inhibitionofPTPopeningmay soonrepresentsanew strategy
to prevent b-cell loss during diabetes mellitus in its various
aspects. Islet transplantation could represent a credible
application. Although substantial progress has occurred
regarding islet isolation and immunosuppression protocols,
34
obstacles still compromise islet transplant success. Islets
(50–70%) are estimated to be destroyed in the immediate
post transplant period,
35 making b-cell apoptosis a crucial
issue that prevents islet transplantation from spreading.
Among several factors, this work suggests that islet
exposure to high glucose and fructose levels might have a
relevantroleingraftdeath.ThereforepreventingPTPopening
during the islet transplant procedure (either by engraftment
outside the splanchnic territory or by pharmacological
inhibition of PTP opening) may enhance b survival and
improve islet transplant outcomes. Conﬁrmatory studies with
Figure 3 Effectof30mMglucoseor2.5mMfructoseonNAD(P)Hautoﬂuorescenceandmitochondrialelectricalmembranepotential.INS-1cellsincubatedinRPMI1640
medium supplemented or not with 1mM CsA for 1h or 100mM metformin for 24h were then incubated in complete RPMI 1640 medium supplemented or not (control) with
glucose(30mM, ﬁnal concentration)or 2.5mM fructoseduring 24h. Cells were then loaded with 20nM TMRM for 30min and theﬂuorescenceof NAD(P)H(blue) and TMRM
(red) were imaged and quantiﬁed as in Figure 2. Results are mean±S.E. of at least ﬁve different experiments. For each experiment, the four conditions were imaged with
exactly the same microscope setting. To facilitate day to day comparisons, NAD(P)H/TMRM surface distribution ratio were normalized (i.e., in order that the NAD(P)H/TMRM
surface distribution ratio in control condition was 1); *Po0.05 versus control,
#Po0.05 versus 30mM glucose,
yPo0.05 versus 2.5mM fructose, unpaired Student’s t-test.
Scale bar, 47mm
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Cell Death and Diseasehuman islets are needed before proposing such a strategy in
clinical trials.
Materials and Methods
Cell culture. Isolated insulinoma cell lines INS-1, a generous gift of Dr. F De
Fraipont (CHU-Grenoble), were maintained in RPMI 1640 medium supplemented
with 10mM HEPES, 10% heat-inactivated fetal calf serum, 2mM L-glutamine,
100U/ml penicillin, 100mg/ml streptomycin, 1mM sodium pyruvate and 50mM
2-mercaptoethanol. Cells were incubated at 371C in a humidiﬁed atmosphere (95%
air, 5% CO2).
Calcium retention capacity assessment. Cells were permeabilized
immediately before the experiment by incubation for 2min at 251C in a buffer
containing 10mM MOPS (pH 7.35), 250mM sucrose, 1mM Pi–Tris, 5mM
succinate and 100mg/ml digitonin. The calcium retention capacity was measured
ﬂuorimetrically usinga PTIQuantamaster C61spectroﬂuorimeter in thepresenceof
0.25mM Calcium Green (Molecular Probes, Illkirch, France) with excitation and
emission wavelengths set at 506 and 527nm, respectively.
Imaging. INS-1cells set on a Lab-Tek-Chamber Slide System (Nalge Nunc
International, Rochester, NY, USA) were studied by time-lapse laser confocal
microscopy at 371C in a humidiﬁed atmosphere (95% air, 5% CO2) using a
microscope equipped with a perfusion chamber (POC chamber, LaCom, Erbach,
Germany) and an incubation system (O2-CO2-1C, PeCom, Erbach, Germany).
Images were collected with a Leica TCS SP2 AOBS inverted laser scanning
confocal microscope equipped with a Coherent 351–364 UV laser (Coherent Inc.,
Santa Clara, CA, USA) laser using a 63  oil immersion objective (HCX PL APO
63.0 X 1.40 W Corr). Laser excitation was 351–364nm for NAD(P)H, and 543nm
for TMRM. Fluorescence emission adjusted with AOBS was 390–486nm for
NAD(P)H, and 565–645nm for TMRM. In order to allow overlay of NAD(P)H and
TMRM signals, image acquisition was set with the same pinhole aperture (Airy
2.03), necessarily increased because of the low signal of NAD(P)H
autoﬂuorescence. Each experiment was performed on a randomly chosen ﬁeld
containing 15–25 cells. Background noise of NADH autoﬂuorescence was removed
by ﬁne ﬁlter (Kernel 3 3) using Volocity software. Image quantiﬁcation was
performed using the ImageJ (NIH images) and Volocity (Improvision, Cergy Saint
Christophe, France) softwares as described in.
22
Cell death induction and drug treatments. For glucose-induced cell
death, cells were incubated for 72h in complete RPMI 1640 medium supplemented
with 19mM D-glucose (ﬁnal concentration, 30Mm D-Glucose). Osmotic control was
performed supplementing RPMI 1640 medium with 19mM mannitol. For fructose-
induced cell death, cells were exposed for 72h to 2.5mM D-fructose. Before these
treatments, INS-1 cells were incubated in the presence, or not, of 1mM CsA for 1h
or 100mM metformin for 24h.
Quantiﬁcation of cell death by ﬂow cytometry. Apoptosis analyses
were performed with a double-stain system using Annexin V (Interchim, Montluc ¸on,
France) combined with FluoProbes 488 and propidium iodide (PI) (Sigma Aldrich,
SaintQuentinFallavier,France).INS-1cellsweredetachedbytrypsination,washed
by centrifugation, and incubated with 100ml of Annexin-V buffer 1  (10mM
HEPES NaOH, pH 7.4, 150mM NaCl, 5mM KCl, 1mM MgCl2 and 1.8mM CaCl2).
Cells were then incubated for 15min at room temperature in the dark in the
presence of 5ml of AnnexinV-FP488. Labeled cells were transferred in a 5ml
propylene tube containing 900ml PBS. A volume of 10ml from a 1mg/ml stock
solution of PI were added to the suspension and immediately analyzed.
Data acquisition (B5000 cells) was carried out using a FACSCAN ﬂow
cytometer (Becton Dickinson Biosciences, Le Pont de Claix, France) equipped with
a 15-mW argon ion laser tuned at 488nm, using the Cell Quest Pro software
(Becton Dickinson Biosciences). Data were plotted as a function of ﬂuorescence
intensity on FL-1 (530nm/30nm band–pass ﬁlter) (Annexin V) and FL-3 channels
(PI) (585–42nm band pass ﬁlter). The Annexin V /PI  population was regarded
as normal healthy cells.
Statistics. Results are presented as means±S.E. The statistical signiﬁcanceof
differences was analyzed using the Student’s t-test. Values were considered to be
different from one another when P-values were lower than 0.05.
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Figure 4 Effects of 30mM glucose or 2.5mM fructose on INS-1 viability. INS-1 cells incubated in RPMI 1640 medium supplemented or not with 1mM CsA for 1h or
100mM metformin for 24h were then incubated in complete RPMI 1640 medium supplemented or not (control) with mannitol (osmotic control for glucose 30mM), glucose
(30mM, ﬁnal concentration) or 2.5mM fructose for 72h. Cell viability was assessed by double labeling as described in Materials and Methods. Histograms represent the
results of three different experiments. Results are mean±S.E.; *Po0.05 versus control,
#Po0.05 versus glucose 30mM 24h,
yPo0,05 versus fructose 2.5mM 24h,
unpaired Student’s t-test
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